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Abstract
Objective—Excessive caloric intake is associated with obesity and adipose tissue dysfunction.
However, the role of dietary cholesterol in this process is unknown. The aim of this study was to
determine whether increasing dietary cholesterol intake alters adipose tissue cholesterol content,
adipocyte size, and endocrine function in nonhuman primates.
Approach and Results—Age-matched, male African Green monkeys (n=5 per group) were
assigned to one of three diets containing 0.002 (Lo), 0.2 (Med) or 0.4 (Hi) mg cholesterol/Kcal.
After 10 weeks of diet feeding, animals were euthanized for adipose tissue, liver, and plasma
collection. With increasing dietary cholesterol, free cholesterol (FC) content and adipocyte size
increased in a step-wise manner in visceral, but not subcutaneous fat, with a significant association
between visceral adipocyte size and FC content (r2=0.298; n=15; p=0.035). In visceral fat, dietary
cholesterol intake was associated with: 1) increased pro-inflammatory gene expression and
macrophage recruitment, 2) decreased expression of genes involved in cholesterol biosynthesis
and lipoprotein uptake, and 3) increased expression of proteins involved in FC efflux.
Conclusions—Increasing dietary cholesterol selectively increases visceral fat adipocyte size,
FC and macrophage content, and proinflammatory gene expression in nonhuman primates.
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Limestone, Lexington, KY 40536-0509, rtemel@wakehealth.edu, Phone: (859) 218-1706, Fax: (859) 257-3235.‡These authors contributed equally to the study
Disclosures
None.
NIH Public Access
Author Manuscript
Arterioscler Thromb Vasc Biol. Author manuscript; available in PMC 2015 September 01.
Published in final edited form as:
Arterioscler Thromb Vasc Biol. 2014 September ; 34(9): 1880–1887. doi:10.1161/ATVBAHA.
114.303896.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Visceral fat cells appear to compensate for increased dietary cholesterol by limiting cholesterol
uptake/synthesis and increasing FC efflux pathways.
Keywords
adipocyte; cholesterol; dietary cholesterol; white adipose tissue; inflammation; African Green
monkey; nonhuman primate
Introduction
Obesity has reached epidemic proportions worldwide. In the US, 67% of adults (>20 yr old)
are overweight (≥25 kg/m2 body mass index (BMI)) or obese (≥30 kg/m2 BMI), resulting in
medical care cost of $147 billion in 2008 1, 2. Obesity increases the risk of other chronic
diseases, such as type 2 diabetes, coronary heart disease, insulin resistance, and non-
alcoholic fatty liver disease 3. Adipocytes are active endocrine cells that secrete adipokines,
store excess energy as triglyceride (TG), release fatty acids during fasting states, and control
systemic glucose disposal 4. During progression of obesity, fat cell size increases due to TG
accretion 5. Larger adipocytes exhibit decreased responsiveness to insulin, decreased
glucose uptake, and increased secretion of proinflammatory adipokines 6–9. Enlarged
adipocytes are associated with macrophage infiltration into adipose tissue, resulting in
increased production of proinflammatory cytokines and insulin resistance 10. Diets high in
calories, saturated fat, and cholesterol (i.e., Western diets) are sufficient to cause obesity in
humans and experimental animals 3, 5. However, the role of individual dietary constituents,
particularly dietary cholesterol, in the development of obesity is poorly understood.
Adipose tissue is a major site for cholesterol storage in man 11. In obese states,
approximately half of the whole body pool of cholesterol is stored in adipose depots. As
adipocyte hypertrophy occurs during development of obesity, cholesterol content also
increases 12. Adipocytes are unique among cells in that nearly all cholesterol (>93%) is
stored in the unesterified form (i.e., free cholesterol, FC) and nearly all of the adipocyte FC
(~88%) is distributed on the TG droplet surface, with the remainder located in the plasma
membrane 13, 14. Dietary cholesterol worsened adipose tissue inflammation in a mouse
model of diet-induced obesity, suggesting that high dietary cholesterol can lead to adipocyte
dysfunction5. Whether dietary cholesterol leads to adipocyte hypertrophy and dysfunction in
humans is unknown and is a difficult question to address experimentally.
To address this gap in knowledge, we studied the effect of dietary cholesterol on adipocyte
size, adipose tissue cholesterol content, and gene/protein expression in a nonhuman primate
atherosclerosis model. We chose this model because of its close phylogenetic relationship to
humans, and because lipid and lipoprotein responses to a Western-type atherogenic diet in
nonhuman primates mimic human responses better than rodent models 15. In addition,
dietary composition is more easily controlled than in humans, and tissues are readily
available for subsequent analyses. Here, we demonstrate that increasing dietary cholesterol
alone was sufficient to drive adipocyte hypertrophy specifically in visceral fat, with
increased adipose tissue FC and inflammatory gene expression in nonhuman primates.
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Results from this study suggest a role for dietary cholesterol in increasing adipocyte
dysfunction, a characteristic feature of the pathogenesis of obesity.
Methods
Materials and Methods are available in the online-only Data Supplement.
Results
Dietary cholesterol increases plasma VLDL and LDL cholesterol
To examine the effect of increasing levels of dietary cholesterol on plasma lipids and
lipoprotein concentrations in African green monkeys, three isocaloric Western-type diets
containing 35% fat with 0.002 (Lo), 0.2 (Med) or 0.4 (Hi) mg cholesterol/kcal were fed to
monkeys. During the 10-week diet feeding period, no significant difference was observed in
food consumption (data not shown), body weight (Figure 1A) or plasma TG levels (Figure
1B). However, there was a striking increase in plasma total cholesterol concentrations (TC)
for the Hi cholesterol group (P<0.0001) relative to the Med and Lo groups, which was
apparent after 3 weeks (Figure 1C). The increase in plasma TC was due, in part, to a
significant increase in VLDL cholesterol (Figure 1D), but was primarily due to large
increases in LDL cholesterol (Figure 1E). Plasma HDL cholesterol concentrations were not
affected by increasing dietary cholesterol (Figure 1F).
The effects of increasing dietary cholesterol on intestinal cholesterol absorption, cholesterol
excretion, and hepatic lipid content were also examined (Table 1). The percentage dietary
cholesterol absorption was similar among all three diet groups (average of 52–56%). Fecal
cholesterol excretion increased in a stepwise manner with increasing dietary cholesterol. In
addition, there was a significant increase of hepatic FC (p=0.0001) and CE (p=0.001)
content with increasing dietary cholesterol, caused primarily by large increases in the Hi
cholesterol group. Hepatic TG content trended higher with increasing dietary cholesterol,
but there were no significant differences among the diet groups, there was also no visible
evidence of hepatic steatosis by histological examination of liver sections (Supplemental
figure I). We also observed changes in hepatic gene expression that were compatible with
the increase in hepatic cholesterol content (Table 2). Specifically, SREBP2 and HMGCR
mRNA expression decreased, whereas ABCG1 expression increased (ABCA1 also trended
upward).
Dietary cholesterol increases cholesterol content and adipocyte size in omental, but not
subcutaneous, adipose tissue
Several studies suggest that adipose cholesterol accumulation correlates with an increased
risk for metabolic syndrome and cardiovascular diseases16, 17. However, it is unclear
whether dietary cholesterol directly affects adipose tissue cholesterol accumulation and, if
so, whether dietary cholesterol accumulation differs among adipose depots. To address this
question, we measured cholesterol levels in omental and subQ adipose tissue. Dietary
cholesterol intake up to 0.4 mg cholesterol/Kcal had no significant effect on subQ adipose
tissue total, free, or esterified cholesterol content (Figure 2A–C, respectively). By contrast,
omental fat total and free cholesterol content was significantly increased in monkeys fed the
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Hi vs. Lo cholesterol diet (Figure 2D–E). Omental fat cholesteryl ester (CE) content was
low (<10% of total cholesterol) and did not vary among diet groups (Figure 2F). To
determine whether dietary cholesterol altered adipocyte hypertrophy in a depot-specific
manner, we examined adipocyte size by analyzing digital images of hematoxylin and eosin-
stained paraffin sections from omental and subQ adipose tissue. Consistent with cholesterol
accumulation, adipocyte size increased with increasing dietary cholesterol in omental fat
(Figure 3A; 42.3 ± 2.4, 49.0 ± 2.7 and 58.9 ± 3.1 µm for Lo, Med, and Hi, respectively), but
not in subQ fat (Figure 3B; p=0.49). Histograms of adipocyte size distribution also
demonstrated a clear shift towards larger size for omental, but not subQ fat. Linear
regression analysis showed a significant correlation (r2 =0.298, p=0.035) between omental
adipose tissue cholesterol content and adipocyte size, but not subQ adipose tissue (r2 =0.048,
p=0.44) (Figure 3C). Collectively, these data demonstrated that increasing dietary
cholesterol in monkeys selectively drives increases in adipose tissue cholesterol content and
adipocyte size in omental fat. There was also a significant (P=.0246, r2=.331) correlation
between plasma LDL cholesterol concentrations and omental adipocyte diameter, suggesting
that elevations in plasma LDL were a primary determinant of increased adipocyte size
(Supplemental Figure II). There was no correlation between VLDL cholesterol
concentrations and adipocyte size.
Dietary cholesterol is associated with omental adipose tissue inflammation
To determine whether the increase of omental fat cholesterol content induced by dietary
cholesterol altered endocrine function, we examined adipokine gene expression by
quantitative real-time PCR. There was a significant increase in expression of the pro-
inflammatory genes interleukin (IL)-6 and IL-8 in the Hi cholesterol diet group relative to
the other groups (Figure 4A). TNFα gene expression trended upward with increasing dietary
cholesterol, but did not reach statistical significance (p=0.065). Next, we examined
macrophage gene expression in omental adipose tissue. There was a significant upregulation
of macrophage recruitment-associated genes, including monocyte chemoattractant protein-1
(MCP-1), C-C chemokine receptor type 2 (CCR2), and the macrophage marker CD68, in Hi
vs. Lo cholesterol diet groups (Figure 4B). We observed no increase in M2 type macrophage
gene expression (Supplemental Figure III A and B) suggesting increasing macrophage
accumulation was primarily M1 type macrophages. Immunofluorescence images of
representative omental adipose tissue suggested increased expression of TNF-α and CD68 in
the Hi vs. Lo cholesterol group (Supplemental Figure IV), but not subcutaneous adipose
tissue (Supplemental Figure V). Cytokine protein expression (TNF-α and IL-6) primarily
co-localized with tissue macrophages (Supplemental figure VI). Despite increased
inflammation, expression of adiponectin and leptin were unaffected by dietary cholesterol
(Figure 4C). In addition, plasma levels of glucose, insulin, or adiponectin were similar
among diet groups (Supplemental figure VII) and TNF-α levels were undetectable,
indicating that 10 weeks of atherogenic diet feeding did not impair insulin sensitivity or
systemic inflammation. These data suggest that increasing dietary cholesterol intake
promotes adipose tissue inflammation and recruitment of macrophages into omental fat, but
in the absence of body weight differences among diet groups, does not lead to systemic
insulin resistance.
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Next, we determined whether an increase in omental fat FC content altered expression of
genes involved in cholesterol biosynthesis, and cellular cholesterol uptake and efflux (Figure
5). SREBP2, a master regulator of cholesterol biosynthesis, was unaffected by dietary
cholesterol (Figure 5A). However, expression of HMG-CoA reductase, the rate-limiting
enzyme for cholesterol biosynthesis, was significantly reduced in Med and Hi cholesterol
diet groups compare to the Lo cholesterol group (Figure 5A). In addition, VLDLr and LDLr
gene expression were significantly lower in the Med and Hi groups compared to the Lo
cholesterol group (Figure 5B). Scavenger receptor class B type I (SR-BI) showed a
decreasing trend with increasing dietary cholesterol (p=0.076). LDLr-related protein (LRP)
gene expression level did not differ among diet groups.
To determine the effect of dietary cholesterol on cholesterol efflux pathways, we analyzed
expression of several genes and proteins involved in adipocyte cholesterol efflux 18, 19.
Adipose tissue ABCA1 and ABCG1 mRNA expression was similar among diet groups, but
apoE expression levels tended to increase with increasing dietary cholesterol (p=0.12;
Figure 5C). However, Western blot analysis revealed an increase in ABCA1 (p=0.053 by
ANOVA; p=0.025 by t-test, Lo vs. Hi) and apoE (p=0.016 by ANOVA) protein expression
with increasing dietary cholesterol (Figure 5D), suggesting an upregulation of cellular
cholesterol efflux pathways. Finally, we also measured expression of several lipogenic genes
and lipoprotein lipase (LPL). Despite increased adipocyte size in omental adipose tissue,
expression of lipogenic genes, including transcription SREBP1c, fatty acid synthase (FAS),
acetyl coA carboxylase (ACC), and LPL, was similar among diet groups (Supplemental
figure IIIC–F). Expression of fatty acid oxidation genes, PPARα and ACOX, was
significantly lower in the Hi vs. Lo cholesterol diet groups (Supplemental figure IIIG–I),
suggesting a decrease in adipose tissue fatty acid oxidation with increasing dietary
cholesterol.
Discussion
Adipose tissue is the largest free cholesterol storage site in the body, and its cholesterol
content affects gene expression and cellular function 20, 21. However, it is unclear whether
dietary cholesterol has a direct impact on adipocyte size, cholesterol content, and metabolic
function. The fundamental question addressed in our study was whether increasing dietary
cholesterol drives adipocyte hypertrophy and inflammation and, if so, whether it occurs in a
fat depot-specific manner. Increasing dietary cholesterol (from 0.002 to 0.4 mg/kcal) was
associated with a selective increase in cholesterol content and adipocyte size in omental
adipose tissue; these relationships were not observed in subQ fat (Figures 1–3). Our data
also revealed that increased visceral fat cholesterol content induced by Hi cholesterol diet
feeding promoted increased expression of genes associated with adipose tissue inflammation
and macrophage recruitment (Figure 4), with cytokine expression primarily associated with
CD68 positive cells (Supplemental figures IV–VI). These changes occurred in the absence
of significant differences in body weight among monkeys consuming the three levels of
dietary cholesterol. Collectively, our work shows that increasing dietary cholesterol alone is
sufficient to induce adipocyte hypertrophy and adipose tissue inflammation selectively in
visceral fat of nonhuman primates.
Chung et al. Page 5
Arterioscler Thromb Vasc Biol. Author manuscript; available in PMC 2015 September 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Whether dietary cholesterol, per se, can affect adipocyte hypertrophy and inflammation is
unknown. Obesity results from excess caloric consumption that often includes increased
dietary cholesterol intake and is associated with adipocyte hypertrophy and increased
recruitment of macrophages into adipose tissue 10. Enlarged adipocytes are insulin resistant,
secrete more proinflammatory cytokines, and have greater basal and catecholamine-
stimulated lipolysis than smaller adipocytes 6–9, 22. Fat cell hypertrophy is associated with
increased adipocyte cholesterol in humans 13, 23 and rodents 24, but whether this occurs
passively with adipocyte TG accumulation during progression of obesity or actively induces
adipocyte hypertrophy is unknown.
Past studies have yielded conflicting results regarding the role of dietary cholesterol on
adipocyte size and cholesterol content. Angel and Farkas documented an increase in rat
adipocyte cholesterol with increasing dietary cholesterol load (0.05% to 5%); however, rats
fed a cholesterol-free diet had more cholesterol in adipocytes than those fed diets containing
0.05% or 0.1% cholesterol, suggesting a complex relationship between dietary cholesterol
intake and adipocyte sterol homeostasis 24. In a recent study, Subramanian et al fed LDLr
knockout mice a high fat (60% cal), high carbohydrate (26% cal) diet with (0.15%) or
without added cholesterol (0.03% from lard in the diet) and showed that added dietary
cholesterol resulted in macrophage infiltration into epididymal fat (i.e., visceral fat depot),
but did not increase adipocyte size. On the other hand, inguinal (i.e., subQ fat depot) fat cells
were increased in size with added dietary cholesterol, but macrophage infiltration was not
observed. Kovanen et al reported that a high cholesterol diet failed to increase adipocyte
cholesterol in rats, but did increase plasma and hepatic cholesterol concentrations 12. No
study to date has examined the interrelationships between dietary cholesterol intake and
adipocyte size, adipose tissue cholesterol content, and inflammatory status.
In this study, we demonstrate that feeding non-human primates diets that were identical
except for increasing level of cholesterol was sufficient to increase visceral fat cell size and
adipose tissue cholesterol and macrophage content. Furthermore, these increases were not
observed in subQ fat and occurred in the absence of body weight differences among diet
groups. The difference in our outcomes (increased visceral adipocyte size, cholesterol and
macrophage content with increasing dietary cholesterol) from those of Subramanian et al
(increased visceral fat macrophage content, but not size) are likely related to the animal
model (monkey vs. LDLr knockout mice) and/or diet composition. Our diets are typical of
the North American diet in total fat content (35% cal) and fatty acid composition (enriched
in saturated and monounsaturated fat). The Hi cholesterol diet is equivalent to consumption
of 3–4 eggs/day for a 2000–2500 calorie/day diet, which might be consumed by individuals
at risk of developing obesity and coronary heart disease. To our knowledge, this is the first
study to show that elevated dietary cholesterol in a typical North American diet can induce
adipocyte hypertrophy and inflammation in nonhuman primates. Thus, high dietary
cholesterol intake may be one causal factor in development of adipose tissue hypertrophy
and inflammation that accompanies obesity, insulin resistance, and type 2 diabetes.
Although we did not observe systemic insulin resistance in our study, likely due to similar
body weights among our groups of nonhuman primates, a longer feeding period may have
resulted in hyperglycemia and/or hyperinsulinemia.
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The increased visceral fat cholesterol content in monkeys fed the Hi cholesterol diet likely
occurred through increased uptake of cholesterol from plasma VLDL and LDL. Supporting
this idea, the Hi cholesterol diet significantly elevated plasma VLDL and LDL cholesterol
concentrations (Figure 1) and we observed a significant correlation between plasma LDL
cholesterol concentrations and omental adipocyte size (Supplemental figure II). Most cells
respond to an increase in FC by converting excess FC to cholesteryl ester via acyl
CoA:cholesterol acyltransferase (ACAT), decreasing de novo cholesterol biosynthesis,
decreasing lipoprotein uptake via downregulation of the LDLr, and increasing efflux of
cholesterol via ABCA1, ABCG1, and SR-BI 25. Adipocytes are unusual in that >95% of
cellular cholesterol is FC and most of their FC is located on the surface of the lipid
droplet 12–14. All of these cellular responses to excess FC are mediated by two master
transcriptional factors, SREBP2 (sterol regulatory element binding protein 2) 26 and LXR
(liver X receptor) 27, which prevent cholesterol uptake/synthesis and stimulate FC efflux,
respectively. In our study, visceral fat from Hi cholesterol-fed monkeys had 50% more FC
compared to monkeys fed the Lo cholesterol diet. Based on visceral fat gene expression
(Figure 5 and Supplemental figure IIIG–I), cholesterol biosynthetic (HMGCR), lipoprotein
receptor (LDLr and VLDLr), and fatty acid oxidation (PPARα and ACOX) gene expression
were down-regulated, suggesting the visceral fat tissue was attempting to compensate for
increased FC content. We 18 and others 19 have shown that ABCA1 expression is critical in
the regulation of adipocyte FC content in mice. Although gene expression of LXR-
responsive genes involved in FC efflux was unaltered by diet (Figure 5C), ABCA1 and apoE
protein expression was significantly higher in Hi vs. Lo cholesterol groups (Figure 5D),
suggesting efflux of FC likely plays a critical role in regulating adipocyte sterol homeostasis
in nonhuman primates as well. Thus, although increased plasma cholesterol has not been
associated with increased adipocyte cholesterol in all studies 24, 28, it is the most likely
explanation for increased visceral fat cholesterol in this one.
Visceral fat is more metabolically active and susceptible to dysfunction relative to subQ
fat 29. In our study, subQ fat did not respond to increased dietary cholesterol intake with a
change in fat cell size, adipose tissue FC content, or inflammatory cytokine expression.
Interestingly, adipocyte size and adipose tissue cholesterol content were 50% greater for
subQ vs. visceral fat in monkeys consuming the Lo cholesterol diet (Figures 2 and 3).
Feeding monkeys the Hi cholesterol diet increased visceral fat cell size and adipose tissue
cholesterol content to levels observed for subQ fat. These results suggest that large fat cell
size or adipose tissue cholesterol content, per se, does not result in inflammation and
dysfunction. The reason for the metabolic differences between visceral vs. subQ fat that lead
to divergent responses to increased dietary cholesterol are unknown and will require further
investigation.
In conclusion, we provide the first evidence that addition of cholesterol to a typical North
American diet selectively induces visceral adipocyte enlargement, adipose tissue cholesterol
accumulation, and inflammatory responses in nonhuman primates. Visceral fat cells appear
to compensate for increased dietary cholesterol by limiting cholesterol uptake/synthesis and
increasing FC efflux pathways. Our results establish new metabolic interrelationships
between dietary cholesterol and adipocyte hypertrophy, adipose tissue cholesterol
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accumulation, and inflammation that may explain part of the metabolic dysfunction that
accompanies diet-induced obesity. Although our study did not specifically address reducing
dietary cholesterol as a means of lowering the risk of adipocyte hypertrophy and
dysfunction, we speculate that this might be the case. If so, recommending a prudent intake
of dietary cholesterol could potentially be a simple strategy to reduce adipocyte hypertrophy
and dysfunction in humans.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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SIGNIFICANCE
Obesity has reached epidemic proportions; 67% of US adults are either overweight or
obese, increasing the risk of other chronic diseases. During progression of obesity, fat
cell size increases, resulting in adipocyte dysfunction and adipose tissue inflammation.
Caloric-rich diets containing saturated fat and cholesterol (i.e., Western diets) are
sufficient to cause obesity in humans and experimental animals. However, the role of
individual dietary constituents, particularly dietary cholesterol, in the development of
obesity is poorly understood. In this study, we provide the first evidence that increasing
dietary cholesterol alone in a typical North American diet selectively induces visceral
adipocyte enlargement, adipose tissue cholesterol accumulation, and inflammatory
responses in nonhuman primates in the absence of significant body weight differences
among animals. Our results establish new metabolic interrelationships between dietary
cholesterol and adipocyte hypertrophy, adipose tissue cholesterol accumulation, and
inflammation that may explain part of the metabolic dysfunction that accompanies diet-
induced obesity.
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Figure 1.
Supplementation of Hi cholesterol diet increases plasma cholesterol in African green
monkeys. African green monkeys were fed atherogenic diets containing 35% calories as fat
and 0.002 (Lo, ○), 0.2 (Med, ▲), or 0.4 (Hi, □) mg cholesterol/kcal for 10 wks. Periodic
blood samples were taken to measure plasma lipid and lipoprotein cholesterol
concentrations, after fractionation of plasma by fast protein liquid chromatography. A. Body
weight of monkeys before (chow diet) and after diet consumption, B. Plasma triglyceride
concentrations, C. Plasma total cholesterol concentrations; Hi cholesterol group was
significantly greater than Med or Lo groups by repeated-measures ANOVA, D. Very low
density lipoprotein cholesterol concentrations, E. Low density lipoprotein cholesterol
concentrations; Hi cholesterol group was significantly greater than Med or Lo groups by
repeated-measures ANOVA, and F. High density lipoprotein cholesterol concentrations.
Each data point represents mean ± SEM; n=5/group.
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Figure 2.
Dietary cholesterol consumption selectively increases cholesterol content in visceral, but not
subQ, adipose tissue. After 10 wks of diet consumption, monkeys were euthanized, adipose
tissue was collected and lipid extracted, and cholesterol content was quantified by gas-liquid
chromatography and normalized to protein content. A–C, Subcutaneous (subQ) total
cholesterol (TC), free cholesterol (FC), and cholesteryl ester (CE). D–F, Omental TC, FC,
and CE. Mean ± SEM; n=5/diet group. *p<0.05 by one-way ANOVA.
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Figure 3.
Dietary cholesterol is associated with increased omental adipose tissue cholesterol content
and size. Adipocyte cell size (n=200/animal) was determined from digital images of
paraffin-embedded, hematoxylin and eosin-stained omental (A) and subQ (B) adipose tissue
sections using Image Pro® software. Mean ± SEM, n=5/diet group. Adipocyte cell size
histograms for all animals within each diet group are shown in the right panel.
Representative images from omental and subQ fat for each diet are shown below the plots in
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panels A and B. C. Correlation of subQ and visceral adipocyte size with cholesterol content
using linear regression analysis. The line of best fit is shown for each plot.
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Figure 4.
An increase in dietary fat is associated with adipose tissue inflammation. Quantitative real-
time PCR analysis of omental fat gene expression in monkeys fed Lo, Med, or Hi dietary
cholesterol. (A) Expression of the proinflammatory genes TNFα, IL-6, and IL-8; (B)
expression of the macrophage recruitment genes MCP-1, CCR2, and CD68 and (C)
expression of the adipokine genes adiponectin and leptin. Data from individual animals are
shown with mean ± SEM denoted by the horizontal lines, n=5/diet group. P values were
obtained by one-way ANOVA with Tukey’s multiple comparison test. Diet groups with
different letters are statistically different, p<0.05.
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Figure 5.
An increase in dietary cholesterol is inversely associated with adipose tissue lipoprotein
receptor gene expression. Omental fat from monkeys fed Lo, Med, or Hi cholesterol diets
(n=5 per group) was analyzed for gene expression by quantitative real-time PCR. Expression
of genes involved in cholesterol biosynthesis (A), lipoprotein/cholesterol uptake (B), and
cholesterol efflux (C). Western blot analysis of ABCA1, apoE, and β-actin from omental
adipose tissue (n=4–5). Relative band intensity quantified by ImageJ software (D). Results
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are mean ± SEM. P value was obtained by one-way ANOVA with Tukey’s multiple
comparison test. Diet groups with different letters are statistically different, p<0.05.
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Table 1
Cholesterol absorption, fecal cholesterol excretion, and hepatic lipid content in African green monkeys fed
different amounts of dietary cholesterol
Lo-chol Med-chol Hi-chol p value
Cholesterol content (mg/Kcal diet) 0.002 0.2 0.4 -
Cholesterol absorption (%) 56.0 ± 5.3 52.0 ± 5.8 52.4 ± 2.2 0.81
Fecal excretion (mg/day/kg BW) 5.5 ± 0.4a 11.40 ± 1.9ab 15.62 ± 2.1b 0.003
Hepatic FC (mg/g protein) 14.33 ± 0.3a 17.4 ± 0.7a 31.2 ± 1.8b 0.0001
Hepatic CE (mg/g protein) 11.36 ± 1.6a 25.0 ±5.1a 158 ± 40.9b 0.001
Hepatic TG (mg/g protein) 39.92 ± 10.3a 57.0 ± 12.6a 67.6 ± 9.4a 0.22
Mean ± SEM, n=5 per diet group. Values with different superscript letter are statistically different (p<0.05) by one-way ANOVA with Tukey’s
multiple comparison test.
BW = body weight; CE = cholesterol ester; FC = fecal cholesterol; TG = triglycerides.
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Table 2
Hepatic gene expression in African green monkeys fed different amounts of dietary cholesterol
Gene Lo-chol Hi-chol p value
SREBP2 1.03 ± 0.13 0.51 ± 0.13 0.02
HMGCR 1.07 ± 0.20 0.48 ± 0.15 0.05
apoE 1.06 ± 0.17 1.22 ± 0.24 n.s
ABCA1 1.13 ± 0.31 1.76 ± 0.55 n.s.
ABCG1 1.17 ± 0.31 3.93 ± 0.84 0.01
SRB1 1.18 ± 0.29 0.72 ± 0.22 n.s.
LDLr 1.18 ± 0.29 3.38 ± 1.90 n.s.
FAS 1.15 ± 0.26 3.72 ± 1.81 n.s
CD36 1.22 ± 0.23 1.47 ± 0.25 n.s
Gene expression was determined by quantitative real time PCR and results were normalized to GAPDH. Results were then normalized to the mean
value for each gene in the Lo-chol group, which was set to a value of 1. Mean ± SEM, n=5 per diet group.
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